Westlake Chemical Partners reports Q3 results (WLKP:NYSE)

Westlake Chemical Partners reported Q3 net income per unit of $0.46, up 9.5% Y/Y, with net income rising 10.7% to $16.2M and total net sales increasing 1.8% to $314.5M, according to the company.

Original reporting
Published Nov 4, 2026, 11:41 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WLKP
Bullish
high confidence
Mentioned
$WLKP
Relevance
7/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$WLKPBullishMed
01

Why it matters

Earnings exceed prior period, indicating operational strength.

02

Market read

First‑report Q3 earnings provide fresh data for traders.

03

What to watch

Potential impact of raw material cost volatility on future margins.

Relevance 7/10Novelty 8/10Timing: today

Background

Press release from Westlake Chemical Partners detailing Q3 financial performance.

Company-level read

Ticker impact

$WLKPBullishHigh confidence
Context

Q3 net income per limited partner unit $0.46, up 9.5% YoY; net income $16.2M, up 10.7% YoY; net sales $314.5M, up 1.8% YoY.

Expected impact

potential modest upside as results exceed prior expectations

Evidence & confidence

First‑report earnings release with better‑than‑expected growth metrics.

Market effects

Chemicals sector may see slight uplift from partner's earnings beat.

U.S. energy‑related investors could adjust positions.

Limited to investors tracking U.S. master limited partnerships.

Counterpoint

Growth rates are modest; market may have already priced in the beat.

Key entities

  • Westlake Chemical Partners

    Master limited partnership in the chemicals industry.

Related articles

$WLKMed

Westlake Chemical Partners LP Q3 2026 Earnings Call Summary

Westlake Chemical Partners LP reported Q3 2026 net income growth due to higher production and sales volumes. Distributable cash flow rose to $18 million, with a trailing 12-month coverage ratio of 1.09x. Management expects modest benefits from rising ethylene prices in Q4 2026 and plans to begin renegotiating the Ethylene Sales Agreement next year. The company maintains a conservative leverage ratio of 1x and has sustained distributions for 49 consecutive quarters.

$WLKPMed

Westlake Chemical Partners LP Announces Third Quarter 2026 Results

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jeff Holy Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Third Quarter 2026 Results • Declared quarterly distribution of $0.4714 per unit; 49 th consecutive quarterly distribution HO

$WLKPMed

Westlake Chemical Partners Q2 Earnings Call Highlights

Westlake Chemical Partners (NYSE:WLKP) reported Q2 net income of $14 million, or $0.40 per unit, and distributable cash flow of $18 million, or $0.50 per unit. The quarterly distribution was $0.4714 per unit, with a 1.04x trailing coverage ratio. Consolidated net sales were $297 million. The partnership extended revolvers through 2031 and leadership shifted to John Bochert as CFO.

$WLKPMed

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (WLKP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 WESTLAKE CHEMICAL PARTNERS LP Contact—(713) 585-2900 Investors—Jonathan Baksht Media—L. Benjamin Ederington Westlake Chemical Partners LP Announces Second Quarter 2026 Results • Declared quarterly distribution of $0.4714 per unit; 48 th consecutive quarterly distribu

$WLKPMedAI 8/10

Westlake Chemical Partners LP Announces Second Quarter 2026 Results

Westlake Chemical Partners LP (NYSE: WLKP) reported Q2 2026 net income attributable to the partnership of $14.2 million, or $0.40 per limited partner unit, versus $14.6 million in Q2 2025. Operating cash flow was $129.8 million. It declared a $0.4714 per unit distribution, 48th consecutive quarter, with trailing twelve-month coverage of 1.04x. Credit facilities were amended to extend maturities to July 2031.